Tonix Pharmaceuticals (@TonixPharma) / X

Tonix Pharmaceuticals

1,374 posts

Tonix Pharmaceuticals

@TonixPharma

Tonix Pharmaceuticals strives to be a leader in providing novel drug therapies and vaccines to improve population health around the world

Berkeley Heights, New Jersey

tonixpharma.com

Joined September 2011

Tonix Pharmaceuticals
@TonixPharma
Jun 23
We’re at #BIO2026! @SethLederman, M.D., CEO, and our Associate Director, Business Development, are highlighting progress across Tonix’s commercial portfolio and development pipeline. See you at Seth’s presentation on Wednesday at 4:45 p.m. PT! #Biotech #Tonix
2.6K
Tonix Pharmaceuticals
@TonixPharma
Jun 18
"It's all in your head." "Everything looks normal." These phrases can delay diagnosis and leave patients suffering for years. In his latest Substack, Tonix CEO Dr. @SethLederman examines the impact of medical gaslighting and why listening to patients matters. Read more:
Gaslighting: Medicine’s 3 Most Dismissive Phrases
From sethmlederman.substack.com
404
Tonix Pharmaceuticals
@TonixPharma
Jun 16
Thanks to @NPR @WBUR @OnPointRadio with Meghna Chakrabarti for inviting #Tonix CEO @SethLederman, M.D. to discuss #Lyme disease! Read/listen here for a deep dive on the disease’s history and innovation, including TNX-4800:
Is it safe for Americans to go into the woods today?
From wbur.org
1.9K
Tonix Pharmaceuticals
@TonixPharma
Jun 11
Tonix CEO @SethLederman writes, "Labels like catastrophizing, learned helplessness, and doctor shopping can hurt patients." His new post explores common experiences among patients with chronic conditions, including #fibromyalgia, and why change is needed:
Labeled and Left Behind: Words That Hurt Care
From sethmlederman.substack.com
405
Tonix Pharmaceuticals
@TonixPharma
Jun 11
We look forward to highlighting our development programs for #Lymedisease, #mpox, and #smallpox, among other #infectiousdiseases, at BTIG's Infectious Disease Day 2026 next week. Learn more: bit.ly/4vefCSX #Tonix
373
Tonix Pharmaceuticals
@TonixPharma
Jun 8
Today we announced another milestone for patient access: a second commercial payer agreement for our fibromyalgia medicine. Learn more: bit.ly/4okolAA #Fibromyalgia #ChronicPain #Tonix
936
Tonix Pharmaceuticals
@TonixPharma
Jun 4
Tonix is at the @eular_org 2026 presenting data on our approved medicine for fibromyalgia in adults. See you there! #Tonix #EULAR2026 #eularCONGRESS #Fibromyalgia
541
Tonix Pharmaceuticals
@TonixPharma
Jun 3
For complex conditions like #fibromyalgia, returning to "normal" doesn't always happen. Symptoms can linger, and patients are often dismissed. Read this article by Tonix CEO @SethLederman on why it's time to support patients with non-linear treatment paths:
When the Illness Ends, But the Symptoms Don’t
From realclearhealth.com
477
Tonix Pharmaceuticals
@TonixPharma
Jun 1
In a new op-ed, Tonix CEO @SethLederman writes, “Caution is a cornerstone of good medicine. But when symptoms don’t let up and providers don’t act, the burden shifts to patients who are desperate for help.” bit.ly/49wnTZE #Fibromyalgia #ChronicIllness #LymeDisease
When Nothing Is Urgent, Patients Get Left Behind
From sethmlederman.substack.com
2.9K
Tonix Pharmaceuticals
@TonixPharma
May 28
We presented a poster at the @ASCPorg Annual Meeting on our real-world, U.S., retrospective claims analysis of opioid use in fibromyalgia: Read more: tinyurl.com/2vpkmh89 #ASCP2026 #Fibromyalgia #ChronicPain #NonOpioid
628
Tonix Pharmaceuticals
@TonixPharma
May 27
Tonix published Phase 1 clinical data for TNX-1500 in the peer-reviewed Journal of Clinical Immunology. Read more about our Phase 2 ready, investigational, anti-CD40L monoclonal antibody: tinyurl.com/bdevtww3 #Tonix #Immunology #KidneyTransplant
660
Tonix Pharmaceuticals
@TonixPharma
May 26
At @ISPOR2026, Tonix presented a poster on a real-world, retrospective claims analysis to further understand patients with fibromyalgia in the U.S.. Read about the findings: bit.ly/4dM62PA
1.9K
Tonix Pharmaceuticals
@TonixPharma
May 19
Thanks to @LymeAlliance for hosting a symposium focused on the latest advances in Lyme last week! We appreciated the opportunity to sponsor the event and present on our investigational monoclonal antibody, TNX-4800. #LymeDisease #LymeDiseaseAwarenessMonth
1.5K